SCHEMBL26868023

SCHEMBL26868023

Nc1cc(CC2CC2)nc2c(C(F)(F)F)cnn12

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 4/20 0.34
MAP3K12 Q12852 2/20 0.34
CHEK1 O14757 3/20 0.32
CCNA2 P20248 3/20 0.32
CDK2 P24941 3/20 0.32
CCNA1 P78396 3/20 0.32
CACNA1H O95180 2/20 0.32
CACNA1G O43497 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
PRKCQ Q04759 1/20 0.30
TYK2 P29597 1/20 0.30
ULK1 O75385 1/20 0.30
ULK2 Q8IYT8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26869019 0.95 CHEK1 (0.33) GRM2MAP3K12CHEK1CCNA2CDK2
SCHEMBL26868953 0.95 CHEK1 (0.33) GRM2MAP3K12CHEK1CCNA2CDK2
SCHEMBL26868021 0.80 CHEK1 (0.36) GRM2CHEK1CCNA2CDK2CCNA1
SCHEMBL26868107 0.78 CHEK1 (0.36) GRM2CHEK1CCNA2CDK2CCNA1
SCHEMBL26868024 0.77 CHEK1 (0.53) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL26868026 0.76 CDK2 (0.37) CHEK1CCNA2CDK2CCNA1
SCHEMBL26868951 0.75 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL26869018 0.75 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL26869017 0.74 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1
SCHEMBL26869090 0.74 CHEK1 (0.37) CHEK1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 EP disclosed